Reinsurance Group of America, Incorporated (RGA) Stock Analysis
RGA is a high-quality, pure-play life reinsurer compounding book value near 10%, with an 8.7/10 quality score and attractive five-year asymmetric upside.
Overview
Reinsurance Group of America is a leading global life and health reinsurer operating across more than 26 countries, with approximately $4.3 trillion of life reinsurance in force and more than $167.1 billion of consolidated assets as of June 30, 2026. It earns premiums from long-term Traditional Reinsurance treaties and investment income from its asset base, supplemented by Financial Solutions such as asset-intensive reinsurance, longevity swaps, capital solutions, and pension risk transfers. **Q2 2026 demonstrated strong earnings momentum:** GAAP net income was $462 million, or $7.01 per diluted share, while adjusted operating income reached $586 million, or $8.89 per share, more than 35% above consensus. Revenue rose 18.5% year over year to $6.637 billion and six-month operating cash flow increased to $3.357 billion. Adjusted operating ROE reached 18.4%, above the 13% to 15% target range, and new-money yield of 6.02% exceeded the 4.96% core portfolio yield. RGA combines a durable moat from biometric data, AURA, and long-term switching costs with a valuation of approximately 8.52x to 10.74x normalized earnings and 1.15x to 1.17x price-to-book. Near-term catalysts include reinvestment at higher yields, additional block transactions, SUP growth, buybacks, and debt repayment. The report’s five-year probability-weighted target is $370.01 versus a $249.50 starting price.